Janet S Winston - JoVE Visualize

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Clinical Laboratory International|June 6, 2017

RAS pathway biomarkers for breast cancer prognosisLauren L Siewertsz van Reesema, Michael P Lee, Vasilena Zheleva, et al.

Head & Neck|September 11, 2003

Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancerSam M Wiseman, Thom R Loree, Nestor R Rigual, et al.

American Journal of Clinical Pathology|September 11, 2002

Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissueDionne C Dillon, Samantha E Easley, Bonnie B Asch, et al.

Annals of Breast Cancer and Therapy|June 17, 2020

Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast CancerGagan Gupta, Caroline Dasom Lee, Mary L Guye, et al.

Cancers|August 28, 2020

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future TherapiesGagan K Gupta, Amber L Collier, Dasom Lee, et al.

Ebiomedicine|August 30, 2016

SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerLauren L Siewertsz van Reesema, Vasilena Zheleva, Janet S Winston, et al.

Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Clinical Laboratory International|June 6, 2017

RAS pathway biomarkers for breast cancer prognosisLauren L Siewertsz van Reesema, Michael P Lee, Vasilena Zheleva, et al.

Head & Neck|September 11, 2003

Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancerSam M Wiseman, Thom R Loree, Nestor R Rigual, et al.

American Journal of Clinical Pathology|September 11, 2002

Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissueDionne C Dillon, Samantha E Easley, Bonnie B Asch, et al.

Annals of Breast Cancer and Therapy|June 17, 2020

Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast CancerGagan Gupta, Caroline Dasom Lee, Mary L Guye, et al.

Cancers|August 28, 2020

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future TherapiesGagan K Gupta, Amber L Collier, Dasom Lee, et al.

Ebiomedicine|August 30, 2016

SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerLauren L Siewertsz van Reesema, Vasilena Zheleva, Janet S Winston, et al.

Pageof 2